Studies carried out on experimental models support this last finding, showing an increased tumour weight and size as a result of leptin injection into melanoma cells, which induces the activation of AKT-based signal transduction pathway and modulates the activity of fatty acid synthase (FASN), an enzyme involved in de novo synthesis of fatty acids (FA) [237,241]. Here, FASN is linked to melanoma.